Sign inGet started

Stengone Carmine N.

Insider CIK 1861519 · KPRX Director · CTNM CEO and President, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CTNM Contineum Therapeutics, In M Exercise deriv2026-09-082026-09-082,500— $0274,430SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-09-082026-09-082,500$1.01 $2.5K19,717SEC↗
CTNM Contineum Therapeutics, In S Sale2026-09-082026-09-082,500$16.46 $41.1K17,217SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-09-082026-09-082,500— $0274,430SEC↗
CTNM Contineum Therapeutics, In S Sale2026-09-082026-09-082,500$16.46 $41.1K17,217SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-09-082026-09-082,500$1.01 $2.5K19,717SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-08-032026-08-032,500— $0276,930SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-08-032026-08-032,500$1.01 $2.5K19,717SEC↗
CTNM Contineum Therapeutics, In S Sale2026-08-032026-08-032,500$16.01 $40.0K17,217SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-08-032026-08-032,500— $0276,930SEC↗
CTNM Contineum Therapeutics, In S Sale2026-08-032026-08-032,500$16.01 $40.0K17,217SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-08-032026-08-032,500$1.01 $2.5K19,717SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-07-082026-07-082,500— $0279,430SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-07-082026-07-082,500$1.01 $2.5K19,717SEC↗
CTNM Contineum Therapeutics, In S Sale2026-07-082026-07-082,500$16.00 $40.0K17,217SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-06-302026-07-017,500— $0281,930SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-06-302026-07-012,500— $0118,417SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-06-302026-07-012,500$1.26 $3.1K27,217SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-06-302026-07-017,500$1.01 $7.6K24,717SEC↗
CTNM Contineum Therapeutics, In S Sale2026-06-302026-07-0110,000$16.01 $160.1K17,217SEC↗
KPRX KIORA PHARMACEUTICALS INC A Award deriv2026-06-102026-06-1225,000— $025,000SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-02-252026-02-262,700— $0120,917SEC↗
CTNM Contineum Therapeutics, In S Sale2026-02-252026-02-262,700$16.02 $43.3K14,954SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-02-252026-02-262,700$1.26 $3.4K17,654SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-02-242026-02-264,400— $0123,617SEC↗
CTNM Contineum Therapeutics, In S Sale2026-02-242026-02-264,400$16.02 $70.5K14,954SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-02-242026-02-264,400$1.26 $5.5K19,354SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2026-02-112026-02-13400— $0128,017SEC↗
CTNM Contineum Therapeutics, In S Sale2026-02-112026-02-13400$16.00 $6.4K14,954SEC↗
CTNM Contineum Therapeutics, In M Exercise2026-02-112026-02-13400$1.26 $50415,354SEC↗
CTNM Contineum Therapeutics, In A Award deriv2026-01-302026-01-30445,000— $0445,000SEC↗
KPRX KIORA PHARMACEUTICALS INC A Award deriv2025-04-012025-04-0220,000— $020,000SEC↗
CTNM Contineum Therapeutics, In A Award deriv2025-01-312025-01-31300,000— $0300,000SEC↗
KPRX KIORA PHARMACEUTICALS INC P Buy2024-09-112024-09-121,250$3.68 $4.6K1,250SEC↗
KPRX KIORA PHARMACEUTICALS INC A Award deriv2024-07-012024-07-031,778— $01,778SEC↗
CTNM Contineum Therapeutics, In A Award deriv2024-05-242024-05-29285,000— $0285,000SEC↗
KPRX KIORA PHARMACEUTICALS INC A Award deriv2023-09-292023-10-038,000— $08,000SEC↗